IL15-induced proliferation of cytotoxic T-cells and NK cells in the circulation or within the lungs could have increased susceptibility of these immune cells to activation-induced cell death when exposed to carboplatin chemotherapy leading to suppressed immune surveillance for tumor cells in circulation or seeded within the pulmonary parenchyma. The gene discussed is IL15; the disease is neoplasm.